Moleculin Biotech, Inc. (MBRX) and Pieris Pharmaceuticals, Inc. (PIRS) Activist Update

0
Moleculin Biotech, Inc. (MBRX) and Pieris Pharmaceuticals, Inc. (PIRS) Activist Update
Broadmark / Pixabay

Sabby Management, LLC has filed an SC 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,502,350 shares of Moleculin Biotech, Inc. (NASDAQ:MBRX). This represents 5.83 percent ownership of the company.

Orbimed Advisors Llc has filed an SC 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,550,000 shares of Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS). This represents 10.88 percent ownership of the company. Previously, Orbimed Advisors Llc had reported owning 5,550,000 shares, indicating a decrease of 0.00 percent. Pieris Pharmaceuticals, Inc. has declared a standard industrial code (sic) of 8731 which is the “Commercial Physical and Biological Research” industry.

When a person or group of persons acquires beneficial ownership of more than 5% of a company’s equity securities, they are required to file a Schedule 13D or 13G with the SEC. If these groups intend to influence management into changing the business strategy, they are considered “activist” investors. There is considerable academic research that suggest activist investors contribute to excess returns in equities in the subsequent twelve months after the event.

Jim Chanos Unveils Lastest Short As Fund Manager Bets On Further Market Declines

Data 1639507577Jim Chanos has a new short target in his sights. Earlier this week, the hedge fund manager disclosed that he is betting against "legacy" data centers that face growing competition from the trio of technology giants, which have previously been their biggest customers. The fund manager, who is best known for his winning bet against Read More

Investors that acquire 10% or more of a company’s shares, or that gain a board seat, are considered insiders by the SEC and are subject to stricter insider trading filing requirements.

New Activist Investor Filings

Investors that acquire more than 5% of the shares of a company and intend to influence management are considered activist investors and must file a 13D.

Walter Investment Management Corp. (WAC) – First Pacific Advisors, LLC has filed a new SC 13D, reporting a 37.80% ownership stake in Walter Investment Management. This is an increase of 1,475.00% from their previous filing.

Reliv’ International, Inc. (RELV) – Montgomery Robert L has filed a new SC 13D, reporting a new ownership stake in Reliv’ International.

CTI Industries Corp. (CTIB) – Schwan John H has filed a new SC 13D, reporting a new ownership stake in CTI Industries.

CTI Industries Corp. (CTIB) – Merrick Company, LLC has filed a new SC 13D, reporting a new ownership stake in CTI Industries.

Amended Activist Investor Filings

Monotype Imaging Holdings, Inc. (TYPE) – Starboard Value LP has filed an amended Schedule 13D/A, reporting a 0.00% ownership stake in Monotype Imaging Holdings. This is a decrease of 100.00% from their previous filing.

Boston Omaha Corporation (BOMN) – Boulderado Partners, LLC has filed an amended Schedule 13D/A, reporting a 12.40% ownership stake in Boston Omaha. This is an increase of 29.30% from their previous filing.

Harmony Merger Corp. (HRMNU) – Halcyon Mount Bonnell Fund Lp has filed an amended Schedule 13D/A, reporting a 8.86% ownership stake in Harmony Merger.

Wesco Aircraft Holdings Inc. (WAIR) – Bancroft Thomas has filed an amended Schedule 13D/A, reporting a 10.90% ownership stake in Wesco Aircraft Holdings. This is an increase of 15.96% from their previous filing.

Regency Centers Corp. (REG) – Gazit-Globe Ltd has filed an amended Schedule 13D/A, reporting a 9.50% ownership stake in Regency Centers. This is a decrease of 9.52% from their previous filing.

WSI Industries, Inc. (WSCI) – Digital Power Corp has filed an amended Schedule 13D/A, reporting a 8.80% ownership stake in WSI Industries. This is an increase of 4.76% from their previous filing.

Pieris Pharmaceuticals, Inc. (PIRS) – Orbimed Advisors Llc has filed an amended Schedule 13D/A, reporting a 10.88% ownership stake in Pieris Pharmaceuticals. This is a decrease of 12.19% from their previous filing.

New Passive Investor Filings

Investors that acquire more than 5% of the shares of a company but have no intention of influencing management are considered passive investors and must file a 13G.

Moleculin Biotech, Inc. (MBRX) – Sabby Management, LLC has filed a new SC 13G, reporting a 5.83% ownership stake in Moleculin Biotech.

Walter Investment Management Corp. (WAC) – Phoenix Investment Adviser LLC has filed a new SC 13G, reporting a 16.27% ownership stake in Walter Investment Management.

Marriott Vacations Worldwide Corp (VAC) – Avery Nicole Marriott has filed a new SC 13G, reporting a 7.60% ownership stake in Marriott Vacations Worldwide.

Integra LifeSciences Holdings Corp. (IART) – Champlain Investment Partners, LLC has filed a new SC 13G, reporting a 5.27% ownership stake in Integra LifeSciences Holdings. This is a decrease of 9.91% from their previous filing.

FNB Bancorp (FNBG) – Brown Trout Management, LLC has filed a new SC 13G, reporting a 5.03% ownership stake in FNB Bancorp.

Electrum Special Acquisition Corporation (ELEC) – City Financial Investment Co Ltd has filed a new SC 13G, reporting a 5.00% ownership stake in Electrum Special Acquisition.

Avinger, Inc. (AVGR) – Empery Asset Management, LP has filed a new SC 13G, reporting a 9.99% ownership stake in Avinger.

Dare Bioscience Inc (DARE) – Empery Asset Management, LP has filed a new SC 13G, reporting a 9.05% ownership stake in Dare Bioscience.

Peabody Energy Corporation (BTU) – Contrarian Capital Management, L.l.c. has filed a new SC 13G, reporting a 9.35% ownership stake in Peabody Energy. This is an increase of 0.54% from their previous filing.

Amended Passive Investor Filings

Phillips 66 (PSX) – Berkshire Hathaway Inc has filed an amended Schedule 13D/A, reporting a 9.80% ownership stake in Phillips 66. This is a decrease of 36.77% from their previous filing.

Atkore International Group Inc. (ATKR) – Levin Capital Strategies, L.p. has filed an amended Schedule 13D/A, reporting a 4.90% ownership stake in Atkore International Group. This is a decrease of 32.88% from their previous filing.

Wiley (JOHN) & Sons, Inc. (JW.A) – Champlain Investment Partners, LLC has filed an amended Schedule 13D/A, reporting a 6.01% ownership stake in Wiley & Sons. This is an increase of 1.18% from their previous filing.

Lydall, Inc. (LDL) – Champlain Investment Partners, LLC has filed an amended Schedule 13D/A, reporting a 7.99% ownership stake in Lydall. This is an increase of 1.14% from their previous filing.

NuVasive, Inc. (NUVA) – Champlain Investment Partners, LLC has filed an amended Schedule 13D/A, reporting a 5.65% ownership stake in NuVasive. This is an increase of 4.05% from their previous filing.

Ritchie Bros. Auctioneers Inc. (RBA) – Champlain Investment Partners, LLC has filed an amended Schedule 13D/A, reporting a 5.70% ownership stake in Ritchie Bros. Auctioneers. This is an increase of 1.06% from their previous filing.

Standex International Corp. (SXI) – Champlain Investment Partners, LLC has filed an amended Schedule 13D/A, reporting a 5.48% ownership stake in Standex International. This is an increase of 0.55% from their previous filing.

TreeHouse Foods, Inc. (THS) – Champlain Investment Partners, LLC has filed an amended Schedule 13D/A, reporting a 5.48% ownership stake in TreeHouse Foods. This is an increase of 0.92% from their previous filing.

Washington Trust Bancorp, Inc. (WASH) – Champlain Investment Partners, LLC has filed an amended Schedule 13D/A, reporting a 5.00% ownership stake in Washington Trust Bancorp. This is an increase of 10.13% from their previous filing.

TriMas Corp. (TRS) – Champlain Investment Partners, LLC has filed an amended Schedule 13D/A, reporting a 4.62% ownership stake in TriMas. This is an increase of 0.65% from their previous filing.

Fintel provides free investor tools for data driven investors. Get full coverage of top rated fund FMR LLC / Fidelity.

Updated on

Fintel® provides advanced research tools for data-driven investors. Fintel currently tracks over 9500 funds and over 63,000 securities traded worldwide. Information includes fund holdings, fund sentiment, financial data, and regulatory filings (including SEC, LSE, ASX, and SGX).
Previous article Longer Lock-Ups Coming?
Next article A Potent Tool For Financial Literacy

No posts to display